Rafael Holdings, Inc. - 02 May 2023 Form 3 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
10%+ Owner
Signature
/s/ William Conkling, CEO
Issuer symbol
CYTH
Transactions as of
02 May 2023
Net transactions value
$0
Form type
3
Filing time
08 May 2023, 17:07:10 UTC
Next filing
02 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CYTH Common Stock, par value $0.0001 per share 2,514,970 02 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYTH Common Stock Warrants (Right to Buy) 02 May 2023 Common Stock 2,514,970 $0.7100 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Warrant is not exercisable until the Issuer has obtained the approval of the shareholders of the Company to the exercise of the Warrant (the "Shareholder Approval Date").
F2 The expiration date is at 5:00 P.M., New York City time, on the seven-year anniversary of the Shareholder Approval Date